The short version of regulatory status fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-08-17 and is reviewed periodically as new material appears.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
| Property | Value | Notes |
|---|---|---|
| Primary research area | Obesity and metabolic regulation | Studied in cell, animal, and human models |
| Highest reported trial phase | Phase II | Public summaries describe mixed results |
| Common route in trials | Subcutaneous injection | Typical for peptide therapeutics |
| Regulatory example | 2013 Australian anti-doping review | Classification was debated at the time |
| Approval status | Not approved as a human medicine | Status can change by jurisdiction |
Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
Football is the most popular sport in Germany. With more than 7 million official members, the German Football Association (Deutscher Fußball-Bund) is the largest single-sport organisation worldwide, and the German top league, the Bundesliga, attracts the second-highest average attendance of all professional sports leagues in the world. The German men's national football team won the FIFA World Cup in 1954, 1974, 1990, and 2014, the UEFA European Championship in 1972, 1980 and 1996, and the FIFA Confederations Cup in 2017. Germany is one of the world's leading motor sports countries, with constructors such as BMW and Mercedes playing prominent roles in international competition. Porsche has won the 24 Hours of Le Mans race 19 times, and Audi 13 times, as of April 2024. The driver Michael Schumacher has set many motor sport records, having won seven Formula One World Drivers' Championships. Sebastian Vettel is also among the most successful Formula One drivers of all time. German athletes historically have been successful contenders in the Olympic Games, ranking third in an all-time Olympic Games medal count when combining East and West German medals prior to German reunification. In 1936, Berlin hosted the Summer Games and the Winter Games in Garmisch-Partenkirchen. Munich hosted the Summer Games of 1972.
===== Ophthalmic division innervation ===== Lacrimal nerve – conveys sensation to the skin areas of the lateral orbital (eye socket) region, except for the lacrimal gland. Frontal nerve – conveys sensation to the skin areas of the forehead and the scalp. Supraorbital nerve – conveys sensation to the skin areas of the eyelids, the forehead, and the scalp. Supratrochlear nerve – conveys sensation to the medial region of the eyelid skin area, and the medial region of the forehead skin. Nasociliary nerve – conveys sensation to the skin area of the nose, and the mucous membrane of the anterior (front) nasal cavity. Anterior ethmoid nerve – conveys sensation in the anterior (front) half of the nasal cavity: (a) the internal areas of the ethmoid sinus and the frontal sinus; and (b) the external areas, from the nasal tip to the rhinion: the anterior tip of the terminal end of the nasal-bone suture. Posterior ethmoid nerve – serves the superior (upper) half of the nasal cavity, the sphenoids, and the ethmoids. Infratrochlear nerve – conveys sensation to the medial region of the eyelids, the palpebral conjunctiva, the nasion (nasolabial junction), and the bony dorsum.
Hohhot Baita International Airport (IATA: HET, ICAO: ZBHH) is an international airport serving Hohhot, the capital of Inner Mongolia, China. It is the largest airport in Inner Mongolia and lies 14.3 km (8.9 mi) east of downtown Hohhot. Its name Baita, meaning White Pagoda, derives from Wanbu Huayanjing Pagoda; one of the historical attractions in Hohhot which lies 5.6 km (3.5 mi) south-east of the airport. In 2025 it served 12,722,692 passengers.
In the 2024 presidential election, Americans aged 18 to 29 voted for Kamala Harris by a margin of only four points, according to exit polls conducted by the Associated Press. Donald Trump and his Republican Party made considerable gains among young voters, especially young men and European Americans. Among Gen-Z women, while those of ethnic-minority backgrounds overwhelmingly supported Harris, those of European ancestry were evenly split between Harris and Trump. This election has broken the historical trend of young people generally voting for Democrats. Generation Z has been shifting towards the right since 2020. Even so, polls conducted after that election showed that the majority of Generation Z disapproved of the performance of President Donald Trump because he had failed to address their concerns about the economy, especially inflation and the cost of living.
=== Pulmonary rehabilitation === Fatigue and loss of muscular mass are common and disabling problems for patients with IPF. Pulmonary rehabilitation may alleviate the overt symptoms of IPF and improve functional status by stabilizing and/or reversing the extrapulmonary features of the disease. The number of published studies on the role of pulmonary rehabilitation in idiopathic pulmonary fibrosis is small, but most of these studies have found significant short-term improvements in functional exercise tolerance, quality of life, and dyspnea on exertion. Typical programs of rehabilitation include exercise training, nutritional modulation, occupational therapy, education and psychosocial counseling. In the late phase of disease, IPF patients tend to discontinue physical activity due to increasing dyspnea. Whenever possible, this should be discouraged.
Sources: en.wikipedia.org
Smashburger sources its ingredients from producers local to its stores, where possible. Chicago-based locations serve burgers made with Sweet Baby Ray's barbecue sauce, while Tennessee burgers use Jack Daniel's BBQ sauce, Florida locations use barbecue sauce containing orange juice, New Orleans locations have a barbecue sauce containing Barq's syrup and Utah locations serve honey barbecue. Telera rolls are used as buns in California restaurants, pretzel buns are served in Chicago restaurants, onion rolls in Minnesota restaurants and brioche in New York restaurants. In 2012, the company launched a program to partner with regional craft beer breweries to serve local beers to pair with its burgers and sandwiches. It promoted the new program with tasting events featuring bloggers and local media. In this program, each burger on Smashburger's menu is paired with a specific beer from the brewer, which is then sold in restaurant locations in that area. The partnerships caused a 30 to 50 percent increase in beer sales in stores, Ryan later said. About 15 to 20 percent of all orders now include a beer order. Among the breweries Smashburger partners with (as of 2016) are Deep Ellum Brewing Co. in Dallas, Summit Brewing Co. in Minneapolis, Sixpoint Brewery in New York, and Christian Moerlein Brewing Co. in Cincinnati.
=== United States === In 2008, Pulver Spirits began developing a line of alcohol powder products to be marketed in the United States. The marketing was reportedly intended to be in full compliance with alcohol regulations and targeted at adults of legal drinking age. In Spring 2014, the Arizona-based company Lipsmark LLC announced that it would start marketing powdered alcohol under the name "Palcohol", a portmanteau of powder + alcohol. This caused considerable controversy, after the product was approved by the TTB for sale. This approval was later attributed to a "labeling error", and the manufacturer surrendered the approvals. In March, 2015, the U.S. Alcohol and Tobacco Tax and Trade Bureau (TTB) approved four powdered alcohol products with the brand name "Palcohol" for sale in the U.S. Under the Twenty-first Amendment to the United States Constitution, state and territory governments also have substantial regulatory powers over "intoxicating liquors", especially regarding retail sales and sales to minors. Shortly after the TTB approval was announced, the U.S. Food and Drug Administration (FDA) responded to inaccurate reports implying that it had approved powdered alcohol as being safe. The FDA clarified that its role was to evaluate the nonalcoholic ingredients and that based on its evaluation of specific powdered alcohol products it had no legal basis to block their entry into the U.S. market. In 2014, Ohio state legislators introduced legislation that would ban Palcohol and all other powdered alcohol. The following year, Iowa state legislators followed suit.
History of nutritional science – progress in general health- and lifespan-related nutritional science List of causes of death by rate – such as R&D on the reduction of environmental toxins Years of potential life lost (YPLL) and Loss of life expectancy (LLE) General medicine and preventive healthcare and interventions against any specific aging-related disease Progress in tools and knowledge that can be used for anti-aging purposes such as CRISPR gene editing General regeneration in humans, organ printing and xenotransplantation progress Research about sustained brain health in general Maintaining health – conventional ways of maintaining and protecting health for life extension Health effects of exercise Neurobiological effects of physical exercise Public health / health policy including environmental policy and consumer protection
== Variation == Many genetic variants of the GC gene are known. They produce 6 main haplotypes and 3 main protein variants (Gc1S, Gc1F and Gc2). The genetic variations are associated with differences in circulating 25-hydroxyvitamin D levels. They have been proposed to account for some of the differences in vitamin D status in different ethnic groups, and have been found to correlate with the response to vitamin D supplementation.
Sources: en.wikipedia.org
No major medicines regulator appears to have approved AOD-9604 for human therapeutic use. It has been studied in clinical trials, but those programs did not result in a marketed drug.
It became prominent during a 2013 Australian sports investigation that examined whether it was a prohibited growth-hormone-related substance. Subsequent interpretations and list updates have varied, so current rules should be checked directly.
Published summaries generally report limited or inconsistent weight-loss effects, and complete trial data are not widely available. The studies were not sufficient to establish it as an effective obesity treatment.
No. It is a synthetic peptide fragment modeled on part of human growth hormone, not the full hormone. It does not contain the complete sequence or receptor-binding regions of hGH.